182 related articles for article (PubMed ID: 2547002)
1. Effects of selective opioid-receptor blockade on the hypothalamo-pituitary-adrenocortical responses to surgical trauma in the rat.
Cover PO; Buckingham JC
J Endocrinol; 1989 May; 121(2):213-20. PubMed ID: 2547002
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro studies on the opioidergic control of the secretion of gonadotrophin-releasing hormone and luteinizing hormone in sexually immature and adult male rats.
Leposavic G; Cover PO; Buckingham JC
Neuroendocrinology; 1991 Jun; 53(6):579-88. PubMed ID: 1652110
[TBL] [Abstract][Full Text] [Related]
3. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.
Buckingham JC; Cooper TA
Neuroendocrinology; 1986; 42(5):421-6. PubMed ID: 3010154
[TBL] [Abstract][Full Text] [Related]
4. Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.
Buckingham JC; Cooper TA
Neuroendocrinology; 1984 May; 38(5):411-7. PubMed ID: 6328347
[TBL] [Abstract][Full Text] [Related]
5. The role of endogenous opioids in neurohypophysial and hypothalamo-pituitary-adrenal axis hormone secretory responses to stress in pregnant rats.
Douglas AJ; Johnstone HA; Wigger A; Landgraf R; Russell JA; Neumann ID
J Endocrinol; 1998 Aug; 158(2):285-93. PubMed ID: 9771473
[TBL] [Abstract][Full Text] [Related]
6. Differences in the effects of mu- and delta-opioid receptor antagonists upon plasma corticosterone levels in stressed mice.
Kitchen I; Rowan KM
Eur J Pharmacol; 1984 May; 101(1-2):153-6. PubMed ID: 6086360
[TBL] [Abstract][Full Text] [Related]
7. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
8. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
Iyengar S; Kim HS; Wood PL
J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
[TBL] [Abstract][Full Text] [Related]
9. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
Iyengar S; Kim HS; Wood PL
Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
[TBL] [Abstract][Full Text] [Related]
10. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
Alcaraz C; Vargas ML; Milanés MV
Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
12. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats.
Manzanares J; Corchero J; Fuentes JA
Brain Res; 1999 Aug; 839(1):173-9. PubMed ID: 10482810
[TBL] [Abstract][Full Text] [Related]
13. Central delta-opioid receptor interactions and the inhibition of reflex urinary bladder contractions in the rat.
Dray A; Nunan L; Wire W
Br J Pharmacol; 1985 Jul; 85(3):717-26. PubMed ID: 2992671
[TBL] [Abstract][Full Text] [Related]
14. Central but not peripheral opiate receptor blockade prolonged pituitary-adrenal responses to stress.
Odio M; Brodish A
Pharmacol Biochem Behav; 1990 Apr; 35(4):963-9. PubMed ID: 2161111
[TBL] [Abstract][Full Text] [Related]
15. Alpha-interferon inhibits adrenocortical secretion via mu 1-opioid receptors in the rat.
Saphier D; Welch JE; Chuluyan HE
Eur J Pharmacol; 1993 May; 236(2):183-91. PubMed ID: 8391456
[TBL] [Abstract][Full Text] [Related]
16. Basal and PAF-, interleukin 1-, ether stress-induced hypothalamic pituitary adrenal secretion of conscious rat: modulation by PAF antagonists.
Rougeot C; Tiberghein C; Minary P; Dray F
J Lipid Mediat; 1991; 4(1):45-59. PubMed ID: 1654152
[TBL] [Abstract][Full Text] [Related]
17. The anticonvulsant effects of DADLE are primarily mediated by activation of delta opioid receptors: interactions between delta and mu receptor antagonists.
Tortella FC; Robles L; Holaday JW
Life Sci; 1985 Aug; 37(6):497-503. PubMed ID: 2991684
[TBL] [Abstract][Full Text] [Related]
18. Role of central opiate receptor subtypes in the circulatory responses of awake rabbits to graded caval occlusions.
Evans RG; Ludbrook J; Van Leeuwen AF
J Physiol; 1989 Dec; 419():15-31. PubMed ID: 2559974
[TBL] [Abstract][Full Text] [Related]
19. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC
Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
